AstraZeneca, Bristol-Myers Oppose "Do Over"

Law360, New York (July 10, 2007, 12:00 AM EDT) -- AstraZeneca LP and Bristol-Myers Squibb Co. have asked a judge to reject plaintiffs' request that the court award them an additional year's worth of damages, pointing out that the group's earlier quest to prove the degree of alleged harm had already failed.

On Monday, the pharmaceutical companies fired back at the plaintiffs, arguing that they were attempting to get away with a "do-over" through their reconsideration motion filed last Thursday.

A slew of big-name pharmaceutical companies, including AstraZeneca and Bristol-Myers, stand accused of laying about average...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.